YOUR CART
- No products in the cart.
Subtotal:
$0.00
BEST SELLING PRODUCTS
Product Name: NPP 100mg
Active Ingredient: Nandrolone Phenylpropionate
Use for: Improved estimina
Concentration: 100mg
Presentation: 10ml
Dosage Men: 200-40mg/week for 6-12 weeks
Ship From: Europe
ACTIVE HALF-LIFE: NANDROLONE PHENYLPROPIONATE 100mg
ACTIVE HALF-LIFE: 5-7 DAYS
CLASSIFICATION: ANABOLIC STEROID
DOSAGE: 300-800 MG/WEEK
ACNE: YES
WATER RETENTION: LOW
HBR: PERHAPS
HEPATOXITY: LOW
AROMATIZATION: NO
Active Half-Life: 2-3 days
Classification: Anabolic Steroid (Nandrolone Phenylpropionate)
Dosage: 100-200 mg every other day
Acne: Possible
Water Retention: Moderate
HBR: Possible (High Blood Pressure)
Hepatotoxicity: Low
Aromatization: Moderate
ACTIVE INGREDIENT: NANDROLONE PHENYLPROPIONATE 100mg
ACTIVE HALF-LIFE: 5-7 DAYS
CLASSIFICATION: ANABOLIC STEROID
DOSAGE: 300-800 MG/WEEK
ACNE: YES
WATER RETENTION: LOW
HBR: PERHAPS
HEPATOXITY: LOW
AROMATIZATION: NO
ACTIVE HALF-LIFE: 2-3 days
CLASSIFICATION: Anabolic Steroid
DOSAGE: Men 200-700 mg/week
ACNE: Rarely
WATER RETENTION: No
HBR: No
HEPATOTOXICITY: Low
AROMATIZATION: Low
MANUFACTURER: Nakon Medical
WAREHOUSE: International Warehouse 12
SUBSTANCE: Nandrolone Phenylpropionate
MAIN SUBSTANCE: NANDROLONE PHENYLPROPIONATE
FORM: INJECTION
MILLILITER SIZE: 10 ML
PACK: VIAL
DOSAGE: 100 MG
DOSAGE UNIT: ML
EAN13: 1379280188838
REFERENCE: CRX006
ACTIVE HALF-LIFE: NANDROLONE PHENYLPROPIONATE 100mg
ACTIVE HALF-LIFE: 5-7 DAYS
CLASSIFICATION: ANABOLIC STEROID
DOSAGE: 300-800 MG/WEEK
ACNE: YES
WATER RETENTION: LOW
HBR: PERHAPS
HEPATOXITY: LOW
AROMATIZATION: NO
ACTIVE HALF-LIFE: NANDROLONE PHENYLPROPIONATE 100mg
ACTIVE HALF-LIFE: 5-7 DAYS
CLASSIFICATION: ANABOLIC STEROID
DOSAGE: 300-800 MG/WEEK
ACNE: YES
WATER RETENTION: LOW
HBR: PERHAPS
HEPATOXITY: LOW
AROMATIZATION: NO
ACTIVE HALF-LIFE: 5-7 DAYS
CLASSIFICATION: Anabolic Steroid
DOSAGE:300-800 MG/WEEK
ACNE: YES
WATER RETENTION: LOW
HBR: PERHAPS
HEPATOTOXICITY: LOW
AROMATIZATION: NO
MANUFACTURER: Beligas Pharmaceuticals
WAREHOUSE: International Warehouse 5